Specialty Pharmacist Transforms HIV Care Outside of the Pharmacy
Drug Topics
NOVEMBER 14, 2024
Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.
Thu.Nov 14, 2024
187 
FDA Approves Eladocagene Exuparvovec-Tneq for Treatment of AADC Deficiency
Pharmacy Times
NOVEMBER 14, 2024
Eladocagene exuparvovec-tneq is the first FDA-approved gene therapy for with aromatic L-amino acid decarboxylase deficiency.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
PTC wins FDA approval for first brain-delivered gene therapy Kebilidi
Fierce Pharma
NOVEMBER 14, 2024
The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy has already been approved to treat AADC deficiency in Europe and the U.K., among other countries, where it's branded as Upstaza.
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Fierce Healthcare
NOVEMBER 14, 2024
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AHA 2024: GLP-1, SGLT2 Treatments May Lower Risk of Future Heart Attack, Stroke for Stroke Survivors
Pharmacy Times
NOVEMBER 14, 2024
The 2024 American Heart Association and American Stroke Association stroke prevention guidelines recommend glucagon-like peptide-1 receptor agonists to reduce the risk of stroke in individuals with diabetes and high cardiovascular risk.
In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex
Fierce Pharma
NOVEMBER 14, 2024
GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
EMA changes tack, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population
Fierce Pharma
NOVEMBER 14, 2024
Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | Upon reexamination, the EMA has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. But the recommendation for approval has a restriction.
Study: Most Children Do Not Receive Interventions Reducing Asthma Exacerbations Despite Effectiveness
Pharmacy Times
NOVEMBER 14, 2024
The intervention methods—annual asthma reviews, inhaler technique checks, and asthma management plans—were most effective when performed in the same visit.
Centene says President Ken Fasola will retire next summer
Fierce Healthcare
NOVEMBER 14, 2024
Centene President Ken Fasola will retire next summer, the insurer revealed | Ken Fasola joined the team at Centene in 2022 when the insurer completed its $2.2 billion acquisition of Magellan Health.
GLP-1 Receptor Agonists Show Promise in Treating Obesity-Related Heart Failure
Pharmacy Times
NOVEMBER 14, 2024
These therapies represent an encouraging advancement in cardiovascular care.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Opinion: How chaplains can help the fractured U.S. health care system
STAT
NOVEMBER 14, 2024
As a medical intern in the late 1980s, I’d occasionally see priests and rabbis on hospital wards, but we basically ignored one another. When we doctors walked into a patient’s room, they’d quickly leave, and when we exited, they’d enter. They seemed to operate in a wholly different realm. After all, we were scientific.
AHA 2024: Patients With Cardiovascular Conditions Want More Guidance About Sexual Health
Pharmacy Times
NOVEMBER 14, 2024
Community pharmacists are playing an increasing role in sexual and reproductive health services and can provide that trustworthy information to patients.
How the Inflation Reduction Act Will Impact Pharmacy Reimbursement | ASPL 2024
Drug Topics
NOVEMBER 14, 2024
Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.
Researchers Assess Burden of RSV Hospitalization Prior to Vaccine Introduction
Pharmacy Times
NOVEMBER 14, 2024
Increasing vaccine coverage among adults at highest risk could lessen associated hospitalizations and severe outcomes caused by RSV.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
GSK hails survival data with revived myeloma drug Blenrep
pharmaphorum
NOVEMBER 14, 2024
GSK's multiple myeloma therapy Blenrep's increase in overall survival in the DREAMM-7 trial has achieved statistical significance
STAT+: FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus
STAT
NOVEMBER 14, 2024
The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing. The regulator criticized Merz for a few reasons concerning Xeomin, which is promoted as an alternative to Botox for combating wrinkle and frown lines.
Allergic Diseases Potentially Increase Risk of Select Mental Health Conditions
Pharmacy Times
NOVEMBER 14, 2024
The strongest association is found between asthma and the risk of attention deficit/hyperactivity disorder, though these links do not equate to causality.
STAT+: Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more
STAT
NOVEMBER 14, 2024
Rise and shine, everyone, another busy day is on the way. We can tell by the sound of the motor vehicles passing by our window and the furious panting of the official mascots as they forage for breakfast on the campus grounds. Even Mrs. Pharmalot is up and about earlier than usual thanks to her own hectic agenda. As for us, we are engaged in the usual ritual of brewing cups of stimulation.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Study Shows Shingles Infection Could Be Associated With Dementia
Pharmacy Times
NOVEMBER 14, 2024
Use of antitherapeutic medication prescribed for herpes zoster related to lower risk of subsequent dementia.
Community Pharmacists Play Key Role in Diabetes Prevention, Management
Drug Topics
NOVEMBER 14, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.
FDA grants accelerated approval for PTC’s AADC deficiency gene therapy
Pharmaceutical Technology
NOVEMBER 14, 2024
The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene therapy in the US that is directly delivered to the brain.
Pharmacist-Led CGM Workflow Could Help Improve Diabetes Outcomes
Drug Topics
NOVEMBER 14, 2024
A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.
Adaptimmune nears second sarcoma approval as Phase II trial hits endpointsÂ
Pharmaceutical Technology
NOVEMBER 14, 2024
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Syncona aims Slingshot at biotech's 'translational gap'
pharmaphorum
NOVEMBER 14, 2024
Syncona launches Slingshot Therapeutics with a mission to find promising projects in academia and translate them into development projects.
BioNTech signs agreement to acquire Biotheus
Pharmaceutical Technology
NOVEMBER 14, 2024
BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a programmed death-ligand 1 and vascular endothelial growth factor A-targeting bispecific antibody.
Does ibuprofen help sore muscles?
The Checkup by Singlecare
NOVEMBER 14, 2024
Injuries. Arthritis. Going bowling for the first time in ten years. Muscle soreness has a lot of causes, and almost as many solutions. But when you roll out of bed and your legs or back scream at you, your first thought might be to grab the ibuprofen. Non-steroidal anti-inflammatory drugs (NSAIDs) are a popular pain reliever for everyone from Olympic champions to people who slept in an awkward position—but does it truly work for sore muscles?
EMA rethinks stance, committee now recommends Leqembi for Alzheimer’s disease
Pharmaceutical Technology
NOVEMBER 14, 2024
Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.
AbbVie’s stumble, Amgen’s tumble and more election fallout
STAT
NOVEMBER 14, 2024
Why are AbbVie executives feeling the M&A blues? What does it take to slice $12 billion from Amgen’s market value? And why are STAT’s D.C. correspondents working so hard? We talk about all that and more on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. It’s a “Chatty Cathy” episode!
AstraZeneca doubles down on US manufacturing with $3.5 billion investment
Outsourcing Pharma
NOVEMBER 14, 2024
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.
STAT+: Mild Alzheimer’s patients won’t save Cassava Sciences
STAT
NOVEMBER 14, 2024
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it’s a good time to correct one of the more egregious misconceptions regarding the handling of patient subgroup data that has been floating persistently around the internet.
AstraZeneca doubles down on US manufacturing with $3.5 billion investment
Outsourcing Pharma
NOVEMBER 14, 2024
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.
Threats to children from anti-vax views, Plan B with higher BMI, a dim view of tech bans for teen mental health
STAT
NOVEMBER 14, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’m back on the newsletter beat today while Theresa’s on holiday, but I’m off to Chicago soon to cover the American Heart Association’s scientific sessions. Ping me if you’ll be following the conference, too.
Can you overdose on Zyrtec?
The Checkup by Singlecare
NOVEMBER 14, 2024
For many people, Zyrtec is the main part of their arsenal against allergy symptoms like sneezing , runny nose , and itchy eyes. This brand-name over-the-counter ( OTC ) drug contains the active ingredient cetirizine , an antihistamine. Like everything else, too much of a good thing can turn into a bad thing. While many people find relief with Zyrtec when using it correctly, others might not be aware of the potential consequences of taking too much.
Let's personalize your content